Advances in the Study of the Antiatherogenic Function and Novel Therapies for HDL

The hypothesis that raising high-density lipoprotein cholesterol (HDL-C) levels could improve the risk for cardiovascular disease (CVD) is facing challenges. There is multitudinous clear clinical evidence that the latest failures of HDL-C-raising drugs show no clear association with risks for CVD. A...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Peiqiu, Pan, Haitao, Xiao, Tiancun, Zhou, Ting, Guo, Jiao, Su, Zhengquan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4581191/
https://www.ncbi.nlm.nih.gov/pubmed/26225968
http://dx.doi.org/10.3390/ijms160817245

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4581191/
https://www.ncbi.nlm.nih.gov/pubmed/26225968
http://dx.doi.org/10.3390/ijms160817245

Ejemplares similares